AngioDynamics Inc falls on lower 2023 results outlook

AngioDynamics

30/03/2023 15:35

(Updates)
    ** Medical technology company AngioDynamics Inc's  ANGO.O 
shares fall 27.6%, hit 2-1/2 year low of $9.10 
    ** Company now expects 2023 net sales between $338 mln and
$342 mln vs prior outlook of $342 mln to $348 mln
    ** Lowers 2023 adjusted loss per share forecast to
$0.06-$0.01 vs prior outlook of profit per share of $0.01-$0.06
    ** Company reports Q3 adjusted loss per share of $0.03,
compared with est of a loss of $0.01 - Refinitiv
    ** As of Feb. 28, ANGO has $30.1 mln in cash and
cash-equivalents
    ** Including session's fall, shares down 34.4% YTD

 (Reporting by Tanya Jain and Pratik Jain in Bengaluru)
 ((Tanya.Jain@thomsonreuters.com))